Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Saroja Pharma Ind
|
Chemo Pharma Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.7 % | 33.33 % | -4.51 % |
|
5yr average Equity Multiplier
|
1.24 | 4.66 | 1.01 |
|
5yr Average Asset Turnover Ratio
|
0.36 | 2.98 | 0.0 |
|
5yr Avg Net Profit Margin
|
71.53 % | 2.08 % | 0.0 |
|
Price to Book
|
2.59 | 0.0 | 1.37 |
|
P/E
|
48.96 | 18.43 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
68.18 Days | 80.28 Days | 0.0 |
|
Inventory Days
|
62.21 Days | 11.27 Days | 0.0 |
|
Days Receivable
|
10.88 Days | 122.72 Days | 0.0 |
|
Days Payable
|
199.95 Days | 47.62 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
815.2 | 2.76 | 794.39 |
|
5yr Avg ROCE
|
19.97 % | 37.65 % | -3.17 % |
|
5yr Avg Operating Profit Margin
|
-101.39 % | 4.76 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | 1.78 | 0.01 |
|
5yr CAGR Net Profit
|
0.0 | 3.81 % | n/a |
|
5yr Average Return on Assets
|
10.86 % | 6.13 % | -4.13 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 73.02 % | 27.89 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.34 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Saroja Pharma Ind
|
Chemo Pharma Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|